OpenLegislation

Paragraph 132

Original text. Later amendments are not shown.

In regulation 165 (omission of regulation 204 (obligation on licensing authority in relation to public announcements))—

(a)

in the heading for “Omission” substitute “Amendment”;

(b)

for “Omit” substitute “In”;

(c)

after “regulation 204” insert “, in paragraph (1), after “pharmacovigilance concerns” insert “which relate to products authorised under a UKMA(NI) or UKMA(UK)”.